Tata India Pharma & Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-1.24%)Nav, as on 08-12-2025

  • Previous Nav

  • Net Change on 08-12-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Regular Plan-Growth -1.17 -0.30 -0.34 21.48 16.15 11.93
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -0.34 21.48 16.15 2.10 1,324.90
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.16 26.63 18.60 1.86 6,437.36
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -1.20 23.45 15.98 2.25 1,124.88

Fund Holdings as on 30-November-2025

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • MAX HEALTHCARE INSTITUTE LTD.

  • HEALTHCARE GLOBAL ENTERPRISES LTD.

  • ABBOTT INDIA LTD.

  • APOLLO HOSPITALS ENTERPRISE LTD.

  • IPCA LABORATORIES LTD.

  • CIPLA LTD.

  • RAINBOW CHILDRENS MEDICARE LTD.

  • LUPIN LTD.

  • AJANTA PHARMA LTD.

  • J.B.CHEMICALS & PHARMACEUTICALS LTD.

  • BAYER CROPSCIENCE LTD.

  • DIVI LABORATORIES LTD.

  • METROPOLIS HEALTHCARE LTD.

  • TORRENT PHARMACEUTICALS LTD.

  • MANKIND PHARMA LTD

  • FDC LTD.

  • ALKEM LABORATORIES LTD.

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.

  • CASH / NET CURRENT ASSET

  • DR. LAL PATH LABS LTD.

  • A) REPO

  • SYNGENE INTERNATIONAL LTD.

  • SAI LIFE SCIENCES LTD

  • COHANCE LIFESCIENCES LTD.

  • FORTIS HEALTHCARE LTD.

  • DR REDDYS LABORATORIES LTD.

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD.

  • VIJAYA DIAGNOSTIC CENTRE LTD.

  • WOCKHARDT LTD.

  • DR. AGARWALS HEALTH CARE LTD.

  • PI INDUSTRIES LTD.

  • ASTER DM HEALTHCARE LTD.

  • HIKAL LTD.

  • JUBILANT PHARMOVA LTD

  • LAXMI DENTAL LIMITED

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Pesticides & Agrochemicals

  • Business Support

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹1,338.85 crore. Tata India Pharma & Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended down ₹-0.38(-1.24%)yesterday to ₹30.2969.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Tata India Pharma & Healthcare Fund is managed by Rajat Srivastava .

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

022 6282 7777
service@tataamc.com
+91 (22) 22613782